Tesamorelin 10 mg

Tesamorelin 10 mg — a stabilised GHRH analogue with a metabolic research profile
Tesamorelin is GHRH with a chemical anchor attached. That single trans-3-hexenoyl modification is what lifts it from a fleeting signal to a durable research compound.

What is Tesamorelin?

Tesamorelin is a synthetic analogue of human growth hormone releasing hormone, consisting of the full 44 amino acid GHRH(1-44) sequence with a trans-3-hexenoyl group attached at the N-terminus. That modification protects the molecule from dipeptidyl peptidase-4 cleavage, the enzymatic step that rapidly inactivates native GHRH. Unlike shorter GHRH analogues, Tesamorelin preserves the complete native sequence, which is part of why it is studied specifically in the context of visceral adipose tissue and metabolic regulation rather than GH release alone.

Research interest

• GHRH receptor pharmacology — used as a stabilised full-length agonist in studies of pituitary somatotroph signalling.
• Visceral adipose research — investigated in research contexts examining regional fat distribution and lipid handling.
• Enzymatic stability design — a clear example of N-terminal acylation used to block DPP-4 mediated inactivation.
• GH/IGF-1 axis dynamics — of interest to researchers mapping downstream hormonal cascades from GHRH receptor activation.
• Comparative analogue work — benchmarked against truncated GHRH analogues to assess the contribution of full-sequence fidelity.

Because Tesamorelin retains the full 44-residue sequence plus a chemical modification, both synthesis quality and conjugation fidelity matter. Batch-Level analytical verification is the only way to confirm the material corresponds to the compound described in the literature.

Specifications

• Content: 10 mg of active peptide per vial
• Form: Lyophilised powder (vial)
• Purity: Pharmaceutical-grade, batch-tested and lot-traceable
• Presentation: Sealed, tamper-evident single vial
• Storage: -20 °C sealed; 2-8 °C short-term

Handling & storage

Keep the sealed vial frozen at -20 °C for extended storage, or at 2-8 °C for short-term laboratory handling. Avoid direct light, moisture ingress and repeated warming and cooling cycles. Store sealed, dry and frozen, protected from light. Warm the vial to room temperature before opening to prevent condensation on the lyophilisate. Reconstitution should follow the laboratory's own validated protocol with a suitable sterile diluent; keep solutions refrigerated, shielded from light and free of repeated freeze-thaw.

Why source it here

• Purity you can document — batch-tested material with traceable lot identification.
• Direct European supply — authentic, sealed vials handled to a strict cold-chain-aware standard.
• No compromise on consistency — controlled sourcing keeps material comparable between orders.
• Rapid discreet dispatch — tracked EU shipping in plain packaging.

For research purposes only. Not a medicinal product. Not for human or veterinary consumption. Intended for qualified laboratory research use only. No statement on this page is a medical claim, and no administration, dosing or protocol guidance is offered or implied.

Related: Peptides · Semaglutide · HGH Frag 176-191 5 mg